BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7974800)

  • 1. The role of radiotherapy in the treatment of stage III non-small cell lung cancer: a survey of clinical practices in Lombardy, Italy, by the Airo*-Lombardia Cooperative Group.
    Palazzi M; Valdagni R; Poli M; Buffoli A; Leoni M; Vavassori V; Di Lorenzo I; Corbella F; Nava S; Cazzaniga LF
    Tumori; 1994 Aug; 80(4):286-9. PubMed ID: 7974800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of radiotherapy in the treatment of carcinoma of the prostate: a survey of clinical practices in Lombardy, Italy, by the AIRO-Lombardia Cooperative Group. Italian Association for Radiation Oncology.
    Villa S; Bertoni F; Bossi A; Caraffini B; Corbella F; Di Lorenzo I; Italia C; Leoni M; Nava S; Sarti E; Vavassori V; Villa E; Palazzi M
    Tumori; 1998; 84(6):636-9. PubMed ID: 10080667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotherapy in Italy for non-small cell lung cancer: patterns of care survey.
    Ramella S; Maranzano E; Frata P; Mantovani C; Lazzari G; Menichelli C; Navarria P; Pergolizzi S; Salvi F
    Tumori; 2012; 98(1):66-78. PubMed ID: 22495704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Image-guided radiotherapy (IGRT) in Lombardy, Italy: a survey by the Lombardy section of the Italian Association of Radiotherapy and Clinical Oncology (AIRO-Lombardy).
    Pedretti S; De Santis MC; Vavassori V; Bortolato B; Colciago RR; Cagna E; Doino DP; Cocchi A; Gerardi MA; Alterio D; Magrini SM; Tonoli S
    Expert Rev Anticancer Ther; 2023 Jun; 23(6):661-667. PubMed ID: 37129314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy for oligometastatic cancer: a survey among radiation oncologists of Lombardy (AIRO-Lombardy), Italy.
    Jereczek-Fossa BA; Bortolato B; Gerardi MA; Dicuonzo S; Arienti VM; Berlinghieri S; Bracelli S; Buglione M; Caputo M; Catalano G; Cazzaniga LF; De Cicco L; Di Muzio N; Filippone FR; Fodor A; Franceschini D; Frata P; Gottardo S; Ivaldi GB; Laudati A; Magrini SM; Mantero E; Meaglia I; Morlino S; Palazzi M; Piccoli F; Romanelli P; Scorsetti M; Serafini F; Scandolaro L; Valdagni R; Orecchia R; Antognoni P;
    Radiol Med; 2019 Apr; 124(4):315-322. PubMed ID: 30554376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperfractionated radiotherapy and concomitant cisplatin in stage III non-small cell lung cancer: a phase II study by the AIRO-Lombardia Cooperative Group.
    Palazzi M; Morrica B; Montanaro P; Cerizza L; Leoni M
    Lung Cancer; 1996 Aug; 15(1):85-91. PubMed ID: 8865126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.
    Zhu J; Li R; Tiselius E; Roudi R; Teghararian O; Suo C; Song H
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011300. PubMed ID: 29247502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approach to the non-operative management of patients with stage II non-small cell lung cancer (NSCLC): A survey of Canadian medical and radiation oncologists.
    Dudani S; Leighl NB; Ho C; Pantarotto JR; Zhu X; Zhang T; Wheatley-Price P
    Lung Cancer; 2016 Apr; 94():74-80. PubMed ID: 26973210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-based analysis of curative therapies in stage II non-small cell lung cancer: the role of radiotherapy in medically inoperable patients.
    Moore S; Leung B; Wu J; Ho C
    Radiat Oncol; 2020 Jan; 15(1):23. PubMed ID: 32000829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant radiotherapy and TKI in metastatic EGFR- or ALK-mutated non-small cell lung cancer: a multicentric analysis on behalf of AIRO lung cancer study group.
    Borghetti P; Bonù ML; Giubbolini R; Levra NG; Mazzola R; Perna M; Visani L; Meacci F; Taraborrelli M; Triggiani L; Franceschini D; Greco C; Bruni A; Magrini SM; Scotti V
    Radiol Med; 2019 Jul; 124(7):662-670. PubMed ID: 30771218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer.
    Sause WT; Scott C; Taylor S; Johnson D; Livingston R; Komaki R; Emami B; Curran WJ; Byhardt RW; Turrisi AT
    J Natl Cancer Inst; 1995 Feb; 87(3):198-205. PubMed ID: 7707407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
    Okawara G; Rusthoven J; Newman T; Findlay B; Evans W
    Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation therapy alone for stage I non-small cell lung cancer.
    Kaskowitz L; Graham MV; Emami B; Halverson KJ; Rush C
    Int J Radiat Oncol Biol Phys; 1993 Oct; 27(3):517-23. PubMed ID: 8226143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET/CT-based adaptive radiotherapy of locally advanced non-small cell lung cancer in multicenter yDEGRO ARO 2017-01 cohort study.
    Mäurer M; Käsmann L; Fleischmann DF; Oertel M; Jazmati D; Medenwald D;
    Radiat Oncol; 2022 Feb; 17(1):29. PubMed ID: 35139856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation therapy of stage I and II non-small cell lung cancer (NSCLC).
    Zierhut D; Bettscheider C; Schubert K; van Kampen M; Wannenmacher M
    Lung Cancer; 2001 Dec; 34 Suppl 3():S39-43. PubMed ID: 11740992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes treating stage III non-small cell lung carcinoma with curative-intent radiotherapy and concurrent carboplatin-paclitaxel chemotherapy.
    Trinh H; Pinkham MB; Lehman M; Zarate D; Dauth M; McGrath M; McCaffrey E; Mai GT; Horwood K
    Clin Respir J; 2016 Jul; 10(4):428-34. PubMed ID: 25353367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reirradiation of recurrent node-positive non-small cell lung cancer after previous stereotactic radiotherapy for stage I disease : A multi-institutional treatment recommendation.
    Nieder C; De Ruysscher D; Gaspar LE; Guckenberger M; Mehta MP; Cheung P; Sahgal A
    Strahlenther Onkol; 2017 Jul; 193(7):515-524. PubMed ID: 28424839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience.
    Sibley GS; Jamieson TA; Marks LB; Anscher MS; Prosnitz LR
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):149-54. PubMed ID: 9422571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current patterns of care for patients with extensive stage small cell lung cancer: Survey of US radiation oncologists on their recommendations regarding thoracic consolidation radiotherapy.
    Mitin T; Jain A; Degnin C; Chen Y; Henderson M; Thomas CR
    Lung Cancer; 2016 Oct; 100():85-89. PubMed ID: 27597285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary bladder preservation for muscle-invasive bladder cancer: a survey among radiation oncologists of Lombardy, Italy.
    Jereczek-Fossa BA; Colombo R; Magnani T; Fodor C; Gerardi MA; Antognoni P; Barsacchi L; Bedini N; Bracelli S; Buffoli A; Cagna E; Catalano G; Gottardo S; Italia C; Ivaldi GB; Masciullo S; Merlotti A; Sarti E; Scorsetti M; Serafini F; Toninelli M; Vitali E; Valdagni R; Villa E; Zerini D; De Cobelli O; Orecchia R
    Tumori; 2015; 101(2):174-8. PubMed ID: 25744865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.